Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 4 OTHER_GOV 2 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 265 Breast Neoplasms, Male 20 Breast Carcinoma In Situ 15 Carcinoma, Non-Small-Cell Lung 13 Prostatic Neoplasms 12 Carcinoma, Intraductal, Noninfiltrating 12 Neoplasm Metastasis 11 Lung Neoplasms 11 Carcinoma, Ductal, Breast 11 Pain 9 Colorectal Neoplasms 9 Colonic Neoplasms 9 Neoplasms 8 Inflammatory Breast Neoplasms 8 Osteoporosis 7 Carcinoma, Ovarian Epithelial 7 Triple Negative Breast Neoplasms 6 Ovarian Neoplasms 6 Fatigue 6 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Testicular Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Sezary Syndrome 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Mycosis Fungoides 4 Multiple Myeloma 4 Melanoma 4 Lymphoma, T-Cell, Cutaneous 4

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × HER2 Positive Breast Cancer × Breast × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡